Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hepatocellular carcinoma-related putative tumor suppressor pseudogene (LPTS pseudogene)
- Target
- LPTS pseudogene
- Molecular classification
- Pseudogene, Long non-coding RNA (lncRNA, inferred from pseudogene context and ceRNA network involvement)
01
Overview
The Hepatocellular carcinoma-related putative tumor suppressor pseudogene (ENSG00000216663) is a non-protein-coding DNA sequence with high similarity to a functional gene but incapable of producing a functional protein. It is classified as a pseudogene and has been implicated in regulatory roles in hepatocellular carcinoma, possibly through the competing endogenous RNA (ceRNA) network, impacting cancer-related pathways such as the p53 signaling pathway. While it has potential as a biomarker for diagnosis and prognosis, there is no evidence that it is a direct therapeutic target, nor are there any drugs known to interact with it. Pseudogene function is still an area of active research, and biological effects may occur through miRNA sponging, RNA-based regulation, or influence on chromatin structure[1][3][6][4].
- Other names
- Hepatocellular carcinoma-related putative tumor suppressor pseudogeneLPTS pseudogeneGC06M112754GC06M112646
02
Mechanism of action
Not targeted by drugs; instead, it may act through regulatory RNA mechanisms such as miRNA sponging or chromatin architecture modulation
03
Biological functions
May act as a competing endogenous RNA (ceRNA), affecting miRNA regulationPossible roles in transcriptional or post-transcriptional regulationPutative involvement in cell proliferation, biological regulation, and growth via regulatory RNA mechanisms
04
Disease associations
Cancer (Hepatocellular carcinoma)
05
Safety considerations
Not applicable; no therapeutic interventions against this pseudogene are reported
06
Biomarkers
Possible prognostic and diagnostic biomarker for hepatocellular carcinoma via expression levels in patient tissues
Beyond the preview
Go deeper on Hepatocellular carcinoma-related putative tumor suppressor pseudogene (LPTS pseudogene).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hepatocellular carcinoma-related putative tumor suppressor pseudogene (LPTS pseudogene).